AusPAR: Caplacizumab

Australian Public Assessment Report

AusPAR

AusPAR: Caplacizumab [Word, 1.19 MB]

AusPAR: Caplacizumab [PDF, 464.39 KB]

AusPAR Attachment 1: Product Information for Caplacizumab [Word, 414.11 KB]

AusPAR Attachment 1: Product Information for Caplacizumab [PDF, 192.23 KB]

Device/Product Name

Cablivi

Active ingredients

Caplacizumab

AusPAR Date

5 May 2020

Published

13 May 2020

Submission Number

PM-2019-02057-1-6

Submission Type

New biological entity

Decision

Approved